These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1378752)

  • 1. Tumor necrosis factor regulates tyrosine phosphorylation on epidermal growth factor receptors in A431 carcinoma cells: evidence for a distinct mechanism.
    Donato NJ; Rosenblum MG; Steck PA
    Cell Growth Differ; 1992 May; 3(5):259-68. PubMed ID: 1378752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early events in the antiproliferative action of tumor necrosis factor are similar to the early events in epidermal growth factor growth stimulation.
    Donato NJ; Ince C; Rosenblum MG; Gallick GE
    J Cell Biochem; 1989 Nov; 41(3):139-57. PubMed ID: 2482293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance of human cervical carcinoma cells to tumor necrosis factor correlates with their increased sensitivity to cisplatin: evidence of a role for DNA repair and epidermal growth factor receptor.
    Nishikawa K; Rosenblum MG; Newman RA; Pandita TK; Hittelman WN; Donato NJ
    Cancer Res; 1992 Sep; 52(17):4758-65. PubMed ID: 1380890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross talk of tumor necrosis factor-alpha and epidermal growth factor in human microvascular endothelial cells.
    Izumi H; Ono M; Ushiro S; Kohno K; Kung HF; Kuwano M
    Exp Cell Res; 1994 Oct; 214(2):654-62. PubMed ID: 7523156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of tumor necrosis factor-alpha on the phosphorylation of tyrosine kinase receptors is associated with dynamic alterations in specific protein-tyrosine phosphatases.
    Ahmad F; Goldstein BJ
    J Cell Biochem; 1997 Jan; 64(1):117-27. PubMed ID: 9015760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression and translocation of protein tyrosine phosphatase 1B-related proteins in ME-180 tumor cells expressing apoptotic sensitivity and resistance to tumor necrosis factor: potential interaction with epidermal growth factor receptor.
    Perez M; Haschke B; Donato NJ
    Oncogene; 1999 Jan; 18(4):967-78. PubMed ID: 10023672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of EGF receptor by tumor necrosis factor-alpha in human hepatocellular carcinoma HepG2 cells.
    Wang D; Yang EB; Cheng LY
    Anticancer Res; 1996; 16(5A):3001-6. PubMed ID: 8917420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor receptor expression and function control cytotoxic responsiveness to tumor necrosis factor in ME-180 squamous carcinoma cells.
    Donato NJ; Yan DH; Hung MC; Rosenblum MG
    Cell Growth Differ; 1993 May; 4(5):411-9. PubMed ID: 8518234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-1 and TNF transmodulate epidermal growth factor receptors by a protein kinase C-independent mechanism.
    Bird TA; Saklatvala J
    J Immunol; 1989 Jan; 142(1):126-33. PubMed ID: 2783320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of tyrosine, serine, and threonine phosphorylation and intracellular processing of the epidermal growth factor receptor by antireceptor monoclonal antibody.
    Sunada H; Yu P; Peacock JS; Mendelsohn J
    J Cell Physiol; 1990 Feb; 142(2):284-92. PubMed ID: 1689318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor activates phospholipase C in rat hepatocytes via a different mechanism from that in A431 or rat1hER cells.
    Liang M; Garrison JC
    Mol Pharmacol; 1992 Nov; 42(5):743-52. PubMed ID: 1435749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of functional epidermal growth factor receptors in a human hematopoietic cell line.
    Oval J; Hershberg R; Gansbacher B; Gilboa E; Schlessinger J; Taetle R
    Cancer Res; 1991 Jan; 51(1):150-6. PubMed ID: 1703031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmented desensitization to epidermal growth factor (EGF) immediate actions: a novel mechanism for altered EGF growth response in mutant A431 cells.
    Karasik A; Reddy SS; Pepinsky RB; Brock T; Kahn CR
    J Cell Physiol; 1990 Feb; 142(2):231-5. PubMed ID: 1689316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of protein phosphorylations in variant A431 cells with different growth responses to epidermal growth factor.
    Buss JE; Chouvet C; Gill GN
    J Cell Physiol; 1984 Jun; 119(3):296-306. PubMed ID: 6202705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies.
    Fan Z; Masui H; Altas I; Mendelsohn J
    Cancer Res; 1993 Sep; 53(18):4322-8. PubMed ID: 8364927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of alpha-interferon on epidermal growth factor-mediated receptor-dependent events.
    Fish EN; Ghislain J; Trogadis J; Stevens JK
    Cancer Res; 1993 Nov; 53(21):5148-57. PubMed ID: 7693332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of the epidermal growth factor receptor by growth-modulating agents: effects of staurosporine, a protein kinase inhibitor.
    Friedman B; Fujiki H; Rosner MR
    Cancer Res; 1990 Feb; 50(3):533-8. PubMed ID: 1688732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of epidermal growth factor receptor tyrosine kinase activity in A431 human epidermoid cells following psoralen/ultraviolet light treatment.
    Mermelstein FH; Abidi TF; Laskin JD
    Mol Pharmacol; 1989 Dec; 36(6):848-55. PubMed ID: 2557535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of epidermal growth factor-stimulated EGF receptor tyrosine kinase activity in A431 human epidermoid carcinoma cells by polyamines.
    Faaland CA; Laskin JD; Thomas TJ
    Cell Growth Differ; 1995 Feb; 6(2):115-21. PubMed ID: 7756170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The protein kinase C inhibitor Go6976 [12-(2-cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole] potentiates agonist-induced mitogen-activated protein kinase activation through tyrosine phosphorylation of the epidermal growth factor receptor.
    Shah BH; Olivares-Reyes JA; Catt KJ
    Mol Pharmacol; 2005 Jan; 67(1):184-94. PubMed ID: 15465928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.